Published in The British journal of dermatology
Bullous pemphigoid (BP) is the most common autoimmune bullous disease. Whether there is an increased risk for subsequent BP among patients with cancer is still unclear. To evaluate the risk for subsequent BP in patients with cancer. This nationwide population-based cohort study was based on data obtained from the Taiwan National Health Insurance Da...
Published in The British journal of dermatology
Published in The British journal of dermatology
Biomarkers of atopic dermatitis (AD) are largely lacking, especially in infant AD. Those that have been examined to date have focused mostly on serum cytokines, with few on noninvasive biomarkers in the skin. We aimed to explore biomarkers obtainable from noninvasive sampling of infant skin. We compared these with plasma biomarkers and structural a...
Published in The British journal of dermatology
Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Tr...
Published in The British journal of dermatology
Published in The British journal of dermatology
The Vitiligo Impact Scale (VIS)-22 is a vitiligo-specific quality-of-life instrument. Its criterion, convergent and known-groups validity, test-retest reliability and responsiveness have been studied previously in an Indian population. The clinical meaning of VIS-22 scores has not yet been analysed. To assign clinical meaning to VIS-22 scores using...
Published in The British journal of dermatology
Published in The British journal of dermatology
Published in The British journal of dermatology
Optical coherence tomography (OCT) is a noninvasive near-infrared light imaging technology that can be utilized to diagnose basal cell carcinomas (BCCs) based on specific morphological features. To conduct a quantitative review using tumour-level data from published studies to assess: (i) the in vivo diagnostic accuracy of different OCT systems; (i...
Published in The British journal of dermatology
Sun protection factor (SPF) is assessed with sunscreen applied at 2 mg cm-2 . People typically apply around 0·8 mg cm-2 and use sunscreen daily for holidays. Such use results in erythema, which is a risk factor for skin cancer. To determine (i) whether typical sunscreen use resulted in erythema, epidermal DNA damage and photoimmunosuppression durin...
